r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AP

Atul Pande

Insider · Director · IMVT

Atul Pande files insider transactions with the SEC as a director of Immunovant (IMVT). We hold 5 disclosed purchases and sales filed since 3 May 2016, 4 of them in the last 90 days.

  • Files forIMVT
  • Disclosed buys and sells5 in all, 4 in the last 90 days
  • Last disclosure28 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 18 December 2019 — 28 August 2026Director · Immunovant (IMVT)38 Form 4 lines · source: SEC Form 4
  • Filed 27 June 2019 — 18 March 2024Director · Karuna Therapeutics (KRTX)74 Form 4 lines · source: SEC Form 4
  • Filed 24 November 2020 — 15 April 2021Director · Sio Gene Therapies (SIOX)2 Form 4 lines · source: SEC Form 4
  • Filed 15 April 2019 — 8 July 2020Director · Axovant Sciences (AXGT)5 Form 4 lines · source: SEC Form 4
  • Filed 29 April 2016 — 15 March 2018Director · Axovant Sciences (AXON)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.